- 全部删除
您的购物车当前为空
(±)13(14)-DiHDPA is a metabolite of docosahexaenoic acid that is produced via oxidation by cytochrome P450 epoxygenases. Epoxygenase metabolites of DHA, including (±)13(14)-DiHDPA, are reported to inhibit angiogenesis, tumor growth, and metastasis.

(±)13(14)-DiHDPA is a metabolite of docosahexaenoic acid that is produced via oxidation by cytochrome P450 epoxygenases. Epoxygenase metabolites of DHA, including (±)13(14)-DiHDPA, are reported to inhibit angiogenesis, tumor growth, and metastasis.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 50 μg | ¥ 2,130 | 35日内发货 | |
| 100 μg | ¥ 3,660 | 35日内发货 | |
| 500 μg | ¥ 14,300 | 35日内发货 | |
| 1 mg | ¥ 23,600 | 35日内发货 |
(±)13(14)-DiHDPA 相关产品
| 产品描述 | (±)13(14)-DiHDPA is a metabolite of docosahexaenoic acid that is produced via oxidation by cytochrome P450 epoxygenases. Epoxygenase metabolites of DHA, including (±)13(14)-DiHDPA, are reported to inhibit angiogenesis, tumor growth, and metastasis. |
| 分子量 | 362.51 |
| 分子式 | C22H34O4 |
| CAS No. | 1345275-24-2 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度信息 | Ethanol: 50 mg/mL (137.93 mM), Sonication is recommended. DMF: 50 mg/mL (137.93 mM), Sonication is recommended. PBS (pH 7.2): 0.25 mg/mL (0.69 mM), Sonication is recommended. DMSO: 50 mg/mL (137.93 mM), Sonication is recommended. |
评论内容